DAVID GRAHAM to Korea
This is a "connection" page, showing publications DAVID GRAHAM has written about Korea.
Connection Strength
0.302
-
Isolation and characterization of tetracycline-resistant clinical isolates of Helicobacter pylori. Antimicrob Agents Chemother. 2000 Nov; 44(11):3203-5.
Score: 0.045
-
Marked differences in the frequency of microsatellite instability in gastric cancer from different countries. Am J Gastroenterol. 1999 Oct; 94(10):3034-8.
Score: 0.042
-
Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J Clin Microbiol. 1999 Jul; 37(7):2274-9.
Score: 0.041
-
One-week triple therapy with lansoprazole, clarithromycin, and metronidazole to cure Helicobacter pylori infection in peptic ulcer disease in Korea. Dig Dis Sci. 1998 Mar; 43(3):464-7.
Score: 0.037
-
High prevalence of duodenal ulcer and gastric cancer in dyspeptic patients in Korea. Scand J Gastroenterol. 1997 Aug; 32(8):751-4.
Score: 0.036
-
Prevalence of Helicobacter pylori infection in Korean children: inverse relation to socioeconomic status despite a uniformly high prevalence in adults. Am J Epidemiol. 1996 Feb 01; 143(3):257-62.
Score: 0.032
-
Horizontal versus familial transmission of Helicobacter pylori. PLoS Pathog. 2008 Oct; 4(10):e1000180.
Score: 0.020
-
Atrophic gastritis in young children and adolescents. J Clin Pathol. 2005 Nov; 58(11):1189-93.
Score: 0.016
-
Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea. J Antimicrob Chemother. 2001 Apr; 47(4):459-61.
Score: 0.012
-
Geographic differences in the distribution of intestinal metaplasia in duodenal ulcer patients. Am J Gastroenterol. 2001 Mar; 96(3):666-72.
Score: 0.012
-
Clarithromycin, amoxycillin and H2-receptor antagonist therapy for Helicobacter pylori peptic ulcer disease in Korea. Aliment Pharmacol Ther. 1997 Oct; 11(5):939-42.
Score: 0.009